If you made any changes in Pure these will be visible here soon.

Research Output 2006 2019

Filter
Letter
2018

Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies

Tiong, I. S., Reynolds, J., Bradstock, K. F., Seymour, J. F., Wei, A. H. & on behalf of the Australasian Leukaemia & Lymphoma Group, 22 Aug 2018, In : Blood Cancer Journal. 8, 9, 5 p., 84.

Research output: Contribution to journalLetterResearchpeer-review

Open Access
File

Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia

Tiong, I. S., Tan, P., McManus, J., Cummings, N., Sadawarte, S., Catalano, J., Hills, R. & Wei, A., 2018, In : Leukemia and Lymphoma. 59, 2, p. 493-496 4 p.

Research output: Contribution to journalLetterResearchpeer-review

2015

Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia

Ling, V., Lee, D., McQuilten, Z., Avery, S., Low, M., Cody, S. H., Nguyen, N-T., McLean, C. A., Gorniak, M. B., Wei, A. & Ting, S. B. N., 1 Dec 2015, In : American Journal of Hematology. 90, 12, p. E219-E220 2 p.

Research output: Contribution to journalLetterOther

2014

Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma

Campbell, P., Walker, P. A., Avery, S., Curtis, D. J., Schwarer, A., Wei, A., Kalff, A., Muirhead, J. L. & Spencer, A., 2014, In : Blood Cancer Journal. 4, 5, p. e213 - e213 3 p.

Research output: Contribution to journalLetterOther

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

Cummins, K. D., Jane, S. M., Nikovic, S., Bazargan, A., Filshie, R. J. A., Sutrave, G., Hertzberg, M., Scott, A., Lane, S., Yannakou, C. K., Ritchie, P. D., D'Rozario, J., Black, J., Bavishi, K. & Wei, A., 2014, In : Blood Cancer Journal. 4, 8, e237.

Research output: Contribution to journalLetterOtherpeer-review

Open Access
File

The role of HiDAC in AML - Author Reply

Wei, A. & Fleming, S. A., 2014, In : Internal Medicine Journal. 44, 8, p. 825 - 825 1 p.

Research output: Contribution to journalLetterOther

2013

Cardiac Imaging in FIP1L1-PDGFRA

Jaworski, C., Looi, J. L., Martin, J. J., Bergin, P., Hare, J., Kaye, D. M., Wei, A. & Taylor, A. J., 2013, In : Journal of the American College of Cardiology. 62, 14, p. 1304 - 1304 1 p.

Research output: Contribution to journalLetterOther

Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome

Coutsouvelis, J., Wiseman, M., Hui, L., Poole, S., Dooley, M., Patil, S., Avery, S., Wei, A. & Spencer, A., Feb 2013, In : British Journal of Clinical Pharmacology. 75, 2, p. 565-568 4 p.

Research output: Contribution to journalLetterOtherpeer-review

Limitations of targeted therapy with sorafenib in elderly high-risk myelodysplastic syndrome and acute myeloid leukemia.

Tan, P. & Wei, A., 2013, In : Leukemia and Lymphoma. 54, 4, p. 675 - 676 2 p.

Research output: Contribution to journalLetterOther

2012

Primed for the kill: occupying Bcl-2 to target death in acute myeloid leukaemia

Wei, A. & Teh, T-C., 2012, In : BioDiscovery. 6, 2, p. 1 - 4 4 p.

Research output: Contribution to journalLetterOther

Rapid detection of FLT3 exon 20 tyrosine kinase domain mutations in patients with acute myeloid leukemia by high-resolution melting analysis

Tan, A., Wong, S., Nyvold, C. G., Carney, D., Wei, A., Seymour, J., Hokland, P., Westerman, U. & Dobrovic, A., 2012, In : Leukemia and Lymphoma. 53, 6, p. 1225 - 1229 5 p.

Research output: Contribution to journalLetterOther

Risk factors for early death after high-dose cytosine arabinoside (HiDAC)-based chemotherapy for adult AML

Van Der Jagt, A., Muirhead, J. L., Seymour, J. F., Bradstock, K. F., Paul, E. & Wei, A., 2012, In : Leukemia. 26, 2, p. 362 - 365 4 p.

Research output: Contribution to journalLetterOther

2010

Revisiting late relapses in acute myeloid leukemia

Minden, M. & Wei, A., 2010, In : Leukemia and Lymphoma. 51, 5, p. 735 - 736 2 p.

Research output: Contribution to journalLetterOther

Salvaging AML with CLAG: Novel option, or more of the same?

Wei, A., 2010, In : Leukemia Research. 35, 3, p. 297 - 298 2 p.

Research output: Contribution to journalLetterOther